Antje Prasse

18PUBLICATIONS
133CO-AUTHORS
AutoimmunityTissue engineeringPredictive and prognostic markersMedical devicesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 25, 2026
Lung fibroblasts contribute to release of serum amyloid A as potential biomarker of exacerbation of lung fibrosis in mice.

|May 08, 2026
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis.

|Feb 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials.

Matthew J Randall, Claus A Andersen, Kevin K Brown

|Jan 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis.

Jürgen Behr, Antje Prasse, Hubert Wirtz

|Dec 08, 2025
The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in idiopathic pulmonary fibrosis.

Theodoros Karampitsakos, Minxue Jia, Bochra Tourki

|Dec 03, 2025
Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling.

Sang-Hun Kim, Jessica Nouws, Jannik Ruwisch

Pageof 3

Frequent Collaborators

7 joint publications

Naftali Kaminski

5 joint publications

Jonas Schupp

3 joint publications

Martin Kolb

3 joint publications

Raphael Borie